Dupilumab side effect in a patient with atopic dermatitis: a case report study

Atopic dermatitis (eczema) is a common chronic disease that is described as severe itching associated with recurrent eczematous lesions. In 2017 the US Food and Drug Administration approved dupilumab for treatment of adults with moderate to severe atopic dermatitis not well controlled with topical t...

Descripción completa

Detalles Bibliográficos
Autores principales: Albader, Sakhar S, Alharbi, Abdulmajeed A, Alenezi, Rakan F, Alsaif, Fahad M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526326/
https://www.ncbi.nlm.nih.gov/pubmed/31190731
http://dx.doi.org/10.2147/BTT.S195512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526326/
https://www.ncbi.nlm.nih.gov/pubmed/31190731
http://dx.doi.org/10.2147/BTT.S195512

Ejemplares similares